Emergency and Critical Care Medicine (Dec 2023)

Treatment of prolonged clonidine-induced autonomic instability with midodrine: a case report about a new approach or a cautionary tale?

  • Saada Malouf,
  • Catherine Henry,
  • Lara Pemberton,
  • Joe-Anthony Rotella

DOI
https://doi.org/10.1097/ec9.0000000000000068
Journal volume & issue
Vol. 3, no. 4
pp. 194 – 197

Abstract

Read online

Abstract. Background. Clonidine is a centrally acting α2 adrenergic and imidazoline-1 receptor agonist that can cause somnolence, bradycardia, and hypotension within several hours of ingestion. Less well-described but observed by us locally is the observation that patients presenting after large overdoses including clonidine can have prolonged autonomic instability. As a result, they may require many days in hospital before recovery. We have previously used midodrine as an indirect antagonist with good effect; however, there are no previous reports of its use for this indication. Case presentation. We present the case of a young female patient who developed prolonged autonomic instability following a large overdose of clonidine (coingested with smaller doses of escitalopram + lisdexamfetamine) that was treated with midodrine but complicated by a type 2 non-ST segment elevated myocardial infarction. Conclusion. Midodrine seems to ameliorate this protracted instability and may provide a means to decrease hospital length of stay in appropriate individuals.